/SOBI Swedish Orphan Biovitrum AB Swedish Orphan Biovitrum Buy, TP SEK315.00 – Healthy revenue growth in Q2e We expect continued healthy revenue growth in Q2 due on 17 July at 0800 CET. However, as in Q1, investments in its commercial platform

SOBI Swedish Orphan Biovitrum AB Swedish Orphan Biovitrum Buy, TP SEK315.00 – Healthy revenue growth in Q2e We expect continued healthy revenue growth in Q2 due on 17 July at 0800 CET. However, as in Q1, investments in its commercial platform

$SOBI #Swedish Orphan Biovitrum AB Swedish Orphan Biovitrum (Buy, TP: SEK315.00) – Healthy revenue growth in Q2e: We expect continued healthy revenue growth in Q2 (due on 17 July at 08:00 CET). However, as in Q1, investments in its commercial platform… https://t.co/L18tUl8IhN https://t.co/s0xqaQVm1A